Ahralgia is commonly caused by which ATT drug
**Question:** Ahralgia is commonly caused by which ATT drug
---
**Core Concept:** Ahralgia refers to the side effect of pain in the jaw or face, which is a common adverse effect of certain Antitubercular Treatment (ATT) drugs. Ahralgia is a manifestation of the drug-induced gum hyperaemia and oedema caused by the combined effects of isoniazid and rifampicin.
**Why the Correct Answer is Right:** Isoniazid is a prodrug that gets activated by acetyl CoA to form hydrazine, which is a potent inhibitor of the nicotinamide adenine dinucleotide (NAD+) reductase enzyme. This enzyme is involved in the synthesis of purines, pyrimidines, and lipids. When inhibited, these pathways lead to increased synthesis of nucleotides, which causes vascular dilatation and increased blood flow to oral tissues. Rifampicin is an inhibitor of the bacterial RNA polymerase enzyme, leading to inhibition of bacterial growth and increased susceptibility of oral tissues to the effects of isoniazid.
**Why Each Wrong Option is Incorrect:**
A. Rifampicin alone does not cause Ahralgia, but it potentiates the effects of isoniazid.
B. Pyrazinamide does not cause Ahralgia as it does not significantly affect oral hemodynamics.
C. Ethambutol is a weak inhibitor of bacterial RNA polymerase and does not cause Ahralgia due to its lesser impact on oral hemodynamics.
D. Ethionamide is a weak inhibitor of bacterial RNA polymerase and does not cause Ahralgia due to its lesser impact on oral hemodynamics.
**Core Concept:** Ahralgia is caused by the combined effects of isoniazid and rifampicin. The key is understanding the pharmacological effects of these drugs and their interaction in causing Ahralgia.
**Why the Correct Answer is Right:** Ahralgia is caused by the combined pharmacological effects of isoniazid and rifampicin. Isoniazid inhibits the enzyme NAD+ reductase, leading to increased vascular dilation and blood flow to the oral tissues. Rifampicin, on the other hand, potentiates the effects of isoniazid by impairing bacterial RNA polymerase, further enhancing the effects of isoniazid on oral hemodynamics.
**Why Each Wrong Option is Incorrect:**
A. Pyrazinamide does not cause Ahralgia as it does not significantly affect oral hemodynamics.
B. Ethambutol is a weak inhibitor of bacterial RNA polymerase and does not cause Ahralgia due to its lesser impact on oral hemodynamics.
C. Ethionamide is a weak inhibitor of bacterial RNA polymerase and does not cause Ahralgia due to its lesser impact on oral hemodynamics.
D. Ethambutol is a weak inhibitor of bacterial RNA polymerase and does not cause Ahralgia due to its lesser impact on oral hemodynamics.
**Clinical Pearl:** Understanding the pharmacological effects of these drugs and their interaction is crucial for diagnosing and managing Ahralgia in patients